市場調査レポート

商品コード

1649660

糖尿病性足潰瘍治療市場規模、シェア、成長分析：治療別、潰瘍タイプ別、最終用途別、地域別 - 産業予測 2025年～2032年

Diabetic Foot Ulcer Treatment Market Size, Share, and Growth Analysis, By Treatment (Wound Care Dressings, Biologics), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers), By End-use, By Region - Industry Forecast 2025-2032

出版日: 2025年02月02日
発行: SkyQuest
ページ情報: 英文 211 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

糖尿病性足潰瘍治療の世界市場規模は2023年に46億4,000万米ドルと評価され、2024年の48億9,000万米ドルから2032年には74億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.4％で成長する見通しです。

糖尿病性足潰瘍治療市場は、糖尿病の有病率の上昇、人口の高齢化、創傷ケア技術の進歩に後押しされ、大きな成長を遂げています。米国では約1億3,000万人が糖尿病または糖尿病予備軍であり、効果的な治療オプションに対する需要が急増しています。また、高齢者人口の増加に伴い、足潰瘍などの糖尿病関連合併症の発生率も増加しています。高度なドレッシング材、生体活性素材、陰圧創傷治療、高気圧酸素療法など、創傷治療における技術革新は治療アプローチに革命をもたらし、創傷治癒の成果を高めています。このような人口動態の動向と技術の進歩が相まって、患者とヘルスケアプロバイダーの両方からの関心が高まり、市場はさらに前進しています。

市場概要
創傷ケア用ドレッシング
- アルギン酸塩ドレッシング
- ハイドロファイバードレッシング
- フォームドレッシング
- フィルムドレッシング
- ハイドロコロイドドレッシング
- サージカルドレッシング
- ハイドロゲルドレッシング
生物学的製剤
- 成長因子
- 皮膚移植
治療機器
- 陰圧閉鎖療法
- 超音波療法
抗生物質
その他

糖尿病性足潰瘍治療市場規模：潰瘍タイプ別& CAGR（2025-2032）

市場概要
神経障害性潰瘍
虚血性潰瘍
神経虚血性潰瘍

糖尿病性足潰瘍治療市場規模：最終用途別& CAGR（2025-2032）

市場概要
病院
外来画像診断センター
ホームケア

糖尿病性足潰瘍治療市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

3M（United States）
Smith+Nephew（United Kingdom）
ConvaTec Group Plc（United Kingdom）
Coloplast A/S（Denmark）
Molnlycke Health Care AB（Sweden）
Integra LifeSciences Holdings Corporation（United States）
Cardinal Health, Inc.（United States）
B. Braun Melsungen AG（Germany）
Medtronic plc（Ireland）
Essity Aktiebolag（publ）（Sweden）
MIMEDX Group, Inc.（United States）
Tissue Regenix Group plc（United Kingdom）
Derma Sciences, Inc.（United States）
Medline Industries, LP（United States）
MPM Medical, Inc.（United States）
Hartmann Group（Germany）
DermaRite Industries, LLC（United States）
BioMonde（United Kingdom）
Sanara MedTech Inc.（United States）

結論と推奨事項

Product Code: SQMIG35D2236

Global Diabetic Foot Ulcer Treatment Market size was valued at USD 4.64 billion in 2023 and is poised to grow from USD 4.89 billion in 2024 to USD 7.45 billion by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The diabetic foot ulcer treatment market is experiencing significant growth, fueled by a rising prevalence of diabetes, an aging population, and advancements in wound care technology. With approximately 130 million individuals in the U.S. affected by diabetes or prediabetes, the demand for effective treatment options is surging. Additionally, as the senior population grows, so does the incidence of diabetes-related complications like foot ulcers. Innovations in wound care, including advanced dressings, bioactive materials, negative pressure wound therapy, and hyperbaric oxygen therapy, are revolutionizing treatment approaches and enhancing wound healing outcomes. This combination of demographic trends and technological advancements is driving increased interest from both patients and healthcare providers, further propelling the market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Foot Ulcer Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetic Foot Ulcer Treatment Market Segments Analysis

Global Diabetic Foot Ulcer Treatment Market is segmented by Treatment, Ulcer Type, End-use and Region. Based on Treatment, the market is segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Others. Based on Ulcer Type, the market is segmented into Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers. Based on End-use, the market is segmented into Hospitals, Ambulatory Imaging Center and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetic Foot Ulcer Treatment Market

The global market for diabetic foot ulcer treatment is witnessing significant growth, driven by innovations in wound care technology including growth factor therapies, bioengineered skin substitutes, and advanced dressings. These advancements not only improve patient outcomes but also expedite the healing process and reduce infection risks. For instance, antimicrobial dressings play a crucial role in preventing common infections associated with diabetic foot ulcers, while bioengineered skin substitutes serve as effective scaffolds for tissue regeneration, promoting faster recovery. The continuous evolution of these state-of-the-art technologies is revolutionizing patient care globally, enhancing the effectiveness and efficiency of treatments for diabetic foot ulcers.

Restraints in the Global Diabetic Foot Ulcer Treatment Market

A significant challenge facing the global diabetic foot ulcer treatment market is the limited accessibility of healthcare resources and facilities in developing countries. In many low- and middle-income nations, particularly in rural areas, the healthcare system remains underdeveloped, leading to inadequate access to specialized care for diabetic foot ulcers. Patients in these regions often struggle to receive timely diagnoses, appropriate wound management, and advanced treatment options. This lack of access may contribute to poorer health outcomes, increased complications, and prolonged healing times, ultimately hindering the overall progress and effectiveness of diabetic foot ulcer interventions on a global scale.

Market Trends of the Global Diabetic Foot Ulcer Treatment Market

The Global Diabetic Foot Ulcer Treatment market is experiencing significant growth driven by the rising prevalence of diabetes worldwide. As diabetic foot ulcers become increasingly common and pose serious health risks, the market is witnessing a shift towards advanced wound care technologies. Innovative solutions such as growth factors, bioengineered skin substitutes, and negative pressure wound therapy are being prioritized, offering more efficient and effective healing alternatives compared to traditional methods. Companies are investing heavily in research and development to launch cutting-edge products that not only expedite healing but also reduce complications, thereby reshaping the treatment landscape for diabetic foot ulcers.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Diabetic Foot Ulcer Treatment Market Size by Treatment & CAGR (2025-2032)

Market Overview
Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam Dressings
- Film Dressing
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
Biologics
- Growth Factors
- Skin Grafts
Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
Antibiotic Medications
Others

Global Diabetic Foot Ulcer Treatment Market Size by Ulcer Type & CAGR (2025-2032)

Market Overview
Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers

Global Diabetic Foot Ulcer Treatment Market Size by End-use & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Imaging Center
Homecare

Global Diabetic Foot Ulcer Treatment Market Size & CAGR (2025-2032)

North America (Treatment, Ulcer Type, End-use)
- US
- Canada
Europe (Treatment, Ulcer Type, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment, Ulcer Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment, Ulcer Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment, Ulcer Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

3M (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConvaTec Group Plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essity Aktiebolag (publ) (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MIMEDX Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissue Regenix Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Derma Sciences, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, LP (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPM Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hartmann Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DermaRite Industries, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMonde (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanara MedTech Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments